资讯
JASCAYD® (nerandomilast) approved in Japan, advancing global access to a new IPF and PPF treatment
Not intended for UK and US audiences
JASCAYD® (nerandomilast) now approved by Japan’s MHLW for the treatment of adults with idiopathic pulmonary fibrosis and adults with progressive pulmonary ...